Related Experiment Video
Updated: May 8, 2026

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
Published on: April 15, 2014
Myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis without cerebral parenchyma involvement
Ren Changhong1, Liu Ming1, Zhou Anna1
1Department of Neurology, National Center for Children'S Health, Beijing Children'S Hospital, Capital Medical University, No.56, Nan Li Shi Road, Beijing, 100045, China.
Abstract:
Since meningoencephalitis with prominent meningeal involvement was first described as a rare phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), sporadic cases have been reported. However, most of the reports were case reports and small sample cohorts. We conducted a retrospective analysis of paediatric patients with MOG antibody-associated meningoencephalitis without cerebral parenchyma involvement on imaging at Beijing Children's Hospital between 2017 and 2024. Upon reviewing the records of 320 MOG antibody-positive paediatric patients in our centre, we identified 18 (6%) patients (median age, 7.2 years; female, 10) with disease onset. The common clinical symptoms were fever (94%), headache (56%), seizure (44%) and vomiting (44%). Most patients had leukocytosis (78%) and elevated ESR and CRP levels (61%). Cerebrospinal fluid analysis revealed intracranial hypertension (28%), leukocytosis (100%) and elevated protein levels (33%). Negative cranial magnetic resonance images were observed in 4 patients, and meningeal enhancement was observed in 14 patients. Fourteen patients showed no improvement with antibiotic therapy but responded effectively to immunotherapy. After a median follow-up of 22 months, 4 (22%) of the 18 patients experienced relapse. At the time of the last follow-up, all patients had a good prognosis (mRS < 2). Conclusion: Meningoencephalitis without parenchymal involvement on MRI represents an underrecognized MOGAD phenotype. The incorporation of this entity into diagnostic criteria and the initiation of early immunotherapy could increase diagnostic sensitivity and reduce relapse risk in children.
Insights
Meningoencephalitis without brain involvement is an underrecognized form of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children. Early immunotherapy improves outcomes and reduces relapse risk in these MOGAD patients.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Meningoencephalitis with meningeal involvement is a rare phenotype of MOGAD.
- Previous reports were limited to case studies and small cohorts.
Purpose of the Study:
- To analyze pediatric MOG antibody-associated meningoencephalitis cases without cerebral parenchymal involvement on imaging.
- To characterize clinical presentation, diagnostic findings, and treatment outcomes.
Main Methods:
- Retrospective analysis of MOG antibody-positive pediatric patients at Beijing Children's Hospital (2017-2024).
- Included patients with meningoencephalitis but no parenchymal brain involvement on MRI.
- Reviewed clinical data, laboratory results, imaging, and treatment responses.
Main Results:
- Identified 18 pediatric patients (6% of MOGAD cohort) with this phenotype.
- Common symptoms included fever, headache, and seizures; laboratory findings showed leukocytosis and elevated inflammatory markers.
- Cranial MRI revealed meningeal enhancement in 14 patients; 4 had negative MRI scans.
- Fourteen patients responded to immunotherapy after failing antibiotics; 22% experienced relapse, but all achieved good prognosis.
Conclusions:
- Meningoencephalitis without parenchymal MRI findings is an underrecognized MOGAD phenotype in children.
- Incorporating this entity into diagnostic criteria and early immunotherapy can improve diagnosis and reduce relapse risk.
More Related Videos
10:47Simple and Efficient Production and Purification of Mouse Myelin Oligodendrocyte Glycoprotein for Experimental Autoimmune Encephalomyelitis Studies
Published on: October 27, 2016
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology